Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Mary Albrecht, A. Lisa Mukherjee, Camlin Tierney, Gene D. Morse, Carrie Dykes, Karin L. Klingman & Lisa M. Demeter. (2011) A Randomized Clinical Trial Evaluating Therapeutic Drug Monitoring (TDM) for Protease Inhibitor–Based Regimens in Antiretroviral-Experienced HIV-Infected Individuals: Week 48 Results of the A5146 Study. HIV Clinical Trials 12:4, pages 201-214.
Read now
Read now
Véronique Joly, Kaoutar Jidar, Mercedes Tatay & Patrick Yeni. (2010) Enfuvirtide: from basic investigations to current clinical use. Expert Opinion on Pharmacotherapy 11:16, pages 2701-2713.
Read now
Read now
Franco Maggiolo, Diego Ripamonti, Monica Airoldi, Annapaola Callegaro, Claudio Arici, Veronica Ravasio, Enrico Bombana, Antonio Goglio & Fredy Suter. (2007) Resistance Costs and Future Drug Options of Antiretroviral Therapies: Analysis of the Role of NRTIs, NNRTIs, and PIs in a Large Clinical Cohort. HIV Clinical Trials 8:1, pages 9-18.
Read now
Read now
Mike Youle, Schlomo Staszweski, Bonaventura Clotet, José Ramon Arribas, Anders Blaxhult, Giampiero Carosi, Edwin DeJesus, Gianni Di Perri, Vicente Estrada, Martin Fisher, Colin Kovacs, Ranjababu Kulasegaram, Adriano Lazzarin, Debbie Marriott, Leopoldo Muñoz, Jacques Reynes, Peter Shalit, Jihad Slim, Chris Tsoukas, Anthony Vaccaro & José Vera. (2006) Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations. HIV Clinical Trials 7:2, pages 86-96.
Read now
Read now
Mike Youle, Schlomo Staszweski, Bonaventura Clotet, José Ramon Arribas, Anders Blaxhult, Giampiero Carosi, Edwin DeJesus, Gianni Di Perri, Vicente Estrada, Martin Fisher, Colin Kovacs, Ranjababu Kulasegaram, Adriano Lazzarin, Debbie Marriott, Leopoldo Muñoz, Jacques Reynes, Peter Shalit, Jihad Slim, Chris Tsoukas, Anthony Vaccaro & José Vera. (2006) Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations. HIV Clinical Trials 7:2, pages 86-96.
Read now
Read now
Articles from other publishers (14)
F. J. Palella, C. Armon, K. Buchacz, J. S. Chmiel, R. M. Novak, R. T. D'Aquila, J. T. Brooks, J. T. Brooks, K. Buchacz, M. D. Durham, K. C. Wood, D. Hankerson, R. Debes, T. Subramanian, C. Akridge, H. Hayes, C. Armon, B. Dean, J. Binkley, S. Bozzette, F. J. Palella, J. S. Chmiel, C. Studney, S. Jahangir, K. A. Lichtenstein, C. Stewart, J. Hammer, K. S. Greenberg, B. Widick, R. Franklin, B. G. Yangco, K. Chagaris, D. Ward, T. Thomas, F. Neale, J. Fuhrer, L. Ording-Bauer, R. Kelly, J. Esteves, E. M. Tedaldi, R. A. Christian, F. Ruley, D. Beadle, P. Graham, R. M. Novak, A. Wendrow, R. Smith, B. Young, B. Widick & M. Scott. (2014) Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS). Journal of Antimicrobial Chemotherapy 69:10, pages 2826-2834.
Crossref
Crossref
Marianne Harris, Bohdan Nosyk, Richard Harrigan, Viviane Dias Lima, Calvin Cohen & Julio Montaner. (2012) Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future. AIDS Research and Treatment 2012, pages 1-8.
Crossref
Crossref
J.A. Girón González, M. Márquez Coello & S. Corchado Páez. (2010) Avances en el tratamiento de la infección por el virus de la inmunodeficiencia humana. Medicine - Programa de Formación Médica Continuada Acreditado 10:69, pages 4716-4725.
Crossref
Crossref
Panel de expertos de Gesida & Plan Nacional sobre el Sida. (2010) Documento de consenso del Grupo de Estudio de Sida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización enero 2010). Enfermedades Infecciosas y Microbiología Clínica 28:6, pages 362.e1-362.e91.
Crossref
Crossref
Mark W Hull, Viviane D Lima, Robert S Hogg, P Richard Harrigan & Julio SG Montaner. (2009) Epidemiology of treatment failure: a focus on recent trends. Current Opinion in HIV and AIDS 4:6, pages 467-473.
Crossref
Crossref
Joaquín Portilla, Vicente Boix, Esperanza Merino & Sergio Reus. (2008) Atazanavir en terapias de rescate. Enfermedades Infecciosas y Microbiología Clínica 26, pages 22-27.
Crossref
Crossref
Kirk M Chan-Tack, Kimberly A Struble, Nathalie Morgensztejn, Jeffrey S Murray, Roy Gulick, Ben Cheng, Ian Weller & Veronica Miller. (2008) HIV clinical trial design for antiretroviral development: moving forward. AIDS 22:18, pages 2419-2427.
Crossref
Crossref
David A. CooperRoy T. SteigbigelJose M. GatellJurgen K. RockstrohChristine KatlamaPatrick YeniAdriano LazzarinBonaventura ClotetPrincy N. KumarJoseph E. EronMauro SchechterMartin MarkowitzMona R. LoutfyJeffrey L. LennoxJing ZhaoJoshua ChenDesmond M. RyanRand R. RhodesJohn A. KillarLucinda R. GildeKim M. StrohmaierAnne R. MeibohmMichael D. MillerDaria J. HazudaMichael L. NesslyMark J. DiNubileRobin D. IsaacsHedy TepplerBach-Yen Nguyen. (2008) Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection. New England Journal of Medicine 359:4, pages 355-365.
Crossref
Crossref
Joseph J. Eron. (2008) Managing Antiretroviral Therapy: Changing Regimens, Resistance Testing, and the Risks from Structured Treatment Interruptions. The Journal of Infectious Diseases 197:s3, pages S261-S271.
Crossref
Crossref
Víctor Julián Moreno Cuerda, Rafael Rubio García & Montserrat Morales Conejo. (2008) Nuevas perspectivas en el del paciente con infección por el virus de la inmunodeficiencia humana politratado y en fracaso virológico. Medicina Clínica 130:2, pages 66-70.
Crossref
Crossref
Jacques ReynesKeikawus ArastéhBonaventura ClotetCalvin CohenDavid A. CooperJean-François DelfraissyJoseph J. EronKeith HenryChristine KatlamaDaniel R. KuritzkesJacob P. LalezariJoep LangeAdriano LazzarinJulio S.G. MontanerMark NelsonMary O' HearnHans-Jürgen StellbrinkBenoit TrottierSharon L. WalmsleyNeil E. BussRalph DeMasiJain ChungLucille DonatacciDenise GuimaraesLucy RowellAdeline ValentineMartin WilkinsonMiklos P. Salgo. (2007) TORO: Ninety-Six-Week Virologic and Immunologic Response and Safety Evaluation of Enfuvirtide with an Optimized Background of Antiretrovirals. AIDS Patient Care and STDs 21:8, pages 533-543.
Crossref
Crossref
Michael M Lederman, Veronica Miller, Ian Weller & Steven G Deeks. (2007) A new approach for ‘deep salvage’ trials in advanced HIV infection. AIDS 21:12, pages 1503-1506.
Crossref
Crossref
J. L?pez Aldeguer. (2007) Recomendaciones de GESIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualizaci?n enero de 2007). Enfermedades Infecciosas y Microbiolog?a Cl?nica 25:1, pages 32-53.
Crossref
Crossref
Steven G Deeks & Jeffrey N Martin. (2007) Partial treatment interruptions. Current Opinion in HIV and AIDS 2:1, pages 46-55.
Crossref
Crossref